Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Axsome Therapeutics (AXSM) Shares Issued (2022 - 2026)

Axsome Therapeutics' Shares Issued history spans 5 years, with the latest figure at $6.3 million for Q1 2026.

  • On a quarterly basis, Shares Issued fell 67.72% to $6.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $54.6 million, a 11.04% increase, with the full-year FY2025 number at $67.9 million, up 66.5% from a year prior.
  • Shares Issued hit $6.3 million in Q1 2026 for Axsome Therapeutics, up from $5.7 million in the prior quarter.
  • Over the last five years, Shares Issued for AXSM hit a ceiling of $243.4 million in Q3 2022 and a floor of $176000.0 in Q2 2022.
  • Historically, Shares Issued has averaged $42.5 million across 5 years, with a median of $11.5 million in 2024.
  • The widest YoY moves for Shares Issued: up 119956.82% in 2023, down 86.13% in 2023.
  • Tracing AXSM's Shares Issued over 5 years: stood at $243.4 million in 2022, then crashed by 86.13% to $33.8 million in 2023, then tumbled by 51.35% to $16.4 million in 2024, then crashed by 65.44% to $5.7 million in 2025, then rose by 11.77% to $6.3 million in 2026.
  • Business Quant data shows Shares Issued for AXSM at $6.3 million in Q1 2026, $5.7 million in Q4 2025, and $9.9 million in Q3 2025.